APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amino Acid Metabolism Disorder Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Amino Acid Metabolism Disorder Drug Industry Growth and Trends Forecast to 2032

19 December 2025103 pages

Choose your research edition.

Industry ResearchAmino Acid Metabolism Disorder Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Amino Acid Metabolism Disorder Drug Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Amino Acid Metabolism Disorder Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amino Acid Metabolism Disorder Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Amino Acid Metabolism Disorder Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

According to APO Research, the global Amino Acid Metabolism Disorder Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Amino Acid Metabolism Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Amino Acid Metabolism Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Amino Acid Metabolism Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Amino Acid Metabolism Disorder Drug market include AMINO, BioMarin, DSM, Kyowa Hakko Kirin, Recordati, Shine Star (Hubei) Biological Engineering, Swedish Orphan Biovitrum, GlaxoSmithKline and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Amino Acid Metabolism Disorder Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Amino Acid Metabolism Disorder Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Amino Acid Metabolism Disorder Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Amino Acid Metabolism Disorder Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Amino Acid Metabolism Disorder Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Amino Acid Metabolism Disorder Drug Market by Company

AMINO

BioMarin

DSM

Kyowa Hakko Kirin

Recordati

Shine Star (Hubei) Biological Engineering

Swedish Orphan Biovitrum

GlaxoSmithKline

Pfizer

Merck

Sanofi

Amino Acid Metabolism Disorder Drug Segment by Type

Folic Acid

Sapropterin Dihydrochloride

Vitamin D

Vitamin B6 & B12

Betaine

Thiamine

Carglumic Acid

Arginine

Others

Amino Acid Metabolism Disorder Drug Segment by Application

Argininosuccinic Acidemia

Citrullinemia

Homocystinuria

Maple Syrup Urine Disease

Phenylketonuria

Amino Acid Metabolism Disorder Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amino Acid Metabolism Disorder Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amino Acid Metabolism Disorder Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amino Acid Metabolism Disorder Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Amino Acid Metabolism Disorder Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Amino Acid Metabolism Disorder Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Amino Acid Metabolism Disorder Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Amino Acid Metabolism Disorder Drug Market Share by Region (2021-2026) Table 4. Global Amino Acid Metabolism Disorder Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Amino Acid Metabolism Disorder Drug Market Share by Region (2027-2032) Table 6. Global Amino Acid Metabolism Disorder Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Amino Acid Metabolism Disorder Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Amino Acid Metabolism Disorder Drug Market Size Share by Type (2021-2026) Table 9. Global Amino Acid Metabolism Disorder Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Amino Acid Metabolism Disorder Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Amino Acid Metabolism Disorder Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Amino Acid Metabolism Disorder Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Amino Acid Metabolism Disorder Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Amino Acid Metabolism Disorder Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Amino Acid Metabolism Disorder Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Amino Acid Metabolism Disorder Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Amino Acid Metabolism Disorder Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Amino Acid Metabolism Disorder Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Amino Acid Metabolism Disorder Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Amino Acid Metabolism Disorder Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Amino Acid Metabolism Disorder Drug Market Size Share by Application (2021-2026) Table 24. Global Amino Acid Metabolism Disorder Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Amino Acid Metabolism Disorder Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Amino Acid Metabolism Disorder Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Amino Acid Metabolism Disorder Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Amino Acid Metabolism Disorder Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Amino Acid Metabolism Disorder Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Amino Acid Metabolism Disorder Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Amino Acid Metabolism Disorder Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Amino Acid Metabolism Disorder Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Amino Acid Metabolism Disorder Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Amino Acid Metabolism Disorder Drug Industry Trends Table 37. Amino Acid Metabolism Disorder Drug Industry Drivers Table 38. Amino Acid Metabolism Disorder Drug Industry Opportunities and Challenges Table 39. Amino Acid Metabolism Disorder Drug Industry Restraints Table 40. Global Amino Acid Metabolism Disorder Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Company (2021-2026) Table 42. Global Amino Acid Metabolism Disorder Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Amino Acid Metabolism Disorder Drug Key Company Headquarters & Area Served Table 44. Global Amino Acid Metabolism Disorder Drug Company, Product Type & Application Table 45. Global Amino Acid Metabolism Disorder Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Amino Acid Metabolism Disorder Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. AMINO Company Information Table 49. AMINO Business Overview Table 50. AMINO Amino Acid Metabolism Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. AMINO Amino Acid Metabolism Disorder Drug Product Portfolio Table 52. AMINO Recent Development Table 53. BioMarin Company Information Table 54. BioMarin Business Overview Table 55. BioMarin Amino Acid Metabolism Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. BioMarin Amino Acid Metabolism Disorder Drug Product Portfolio Table 57. BioMarin Recent Development Table 58. DSM Company Information Table 59. DSM Business Overview Table 60. DSM Amino Acid Metabolism Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. DSM Amino Acid Metabolism Disorder Drug Product Portfolio Table 62. DSM Recent Development Table 63. Kyowa Hakko Kirin Company Information Table 64. Kyowa Hakko Kirin Business Overview Table 65. Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Product Portfolio Table 67. Kyowa Hakko Kirin Recent Development Table 68. Recordati Company Information Table 69. Recordati Business Overview Table 70. Recordati Amino Acid Metabolism Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Recordati Amino Acid Metabolism Disorder Drug Product Portfolio Table 72. Recordati Recent Development Table 73. Shine Star (Hubei) Biological Engineering Company Information Table 74. Shine Star (Hubei) Biological Engineering Business Overview Table 75. Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Product Portfolio Table 77. Shine Star (Hubei) Biological Engineering Recent Development Table 78. Swedish Orphan Biovitrum Company Information Table 79. Swedish Orphan Biovitrum Business Overview Table 80. Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Product Portfolio Table 82. Swedish Orphan Biovitrum Recent Development Table 83. GlaxoSmithKline Company Information Table 84. GlaxoSmithKline Business Overview Table 85. GlaxoSmithKline Amino Acid Metabolism Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. GlaxoSmithKline Amino Acid Metabolism Disorder Drug Product Portfolio Table 87. GlaxoSmithKline Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Amino Acid Metabolism Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Pfizer Amino Acid Metabolism Disorder Drug Product Portfolio Table 92. Pfizer Recent Development Table 93. Merck Company Information Table 94. Merck Business Overview Table 95. Merck Amino Acid Metabolism Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Merck Amino Acid Metabolism Disorder Drug Product Portfolio Table 97. Merck Recent Development Table 98. Sanofi Company Information Table 99. Sanofi Business Overview Table 100. Sanofi Amino Acid Metabolism Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Sanofi Amino Acid Metabolism Disorder Drug Product Portfolio Table 102. Sanofi Recent Development Table 103. North America Amino Acid Metabolism Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Amino Acid Metabolism Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Amino Acid Metabolism Disorder Drug Market Share by Country (2021-2026) Table 106. North America Amino Acid Metabolism Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Amino Acid Metabolism Disorder Drug Market Share Forecast by Country (2027-2032) Table 108. Europe Amino Acid Metabolism Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 110. Europe Amino Acid Metabolism Disorder Drug Market Share by Country (2021-2026) Table 111. Europe Amino Acid Metabolism Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Europe Amino Acid Metabolism Disorder Drug Market Share Forecast by Country (2027-2032) Table 113. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 115. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Share by Country (2021-2026) Table 116. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Share Forecast by Country (2027-2032) Table 118. Latin America Amino Acid Metabolism Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Latin America Amino Acid Metabolism Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 120. Latin America Amino Acid Metabolism Disorder Drug Market Share by Country (2021-2026) Table 121. Latin America Amino Acid Metabolism Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Latin America Amino Acid Metabolism Disorder Drug Market Share Forecast by Country (2027-2032) Table 123. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 125. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Share by Country (2021-2026) Table 126. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Share Forecast by Country (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Amino Acid Metabolism Disorder Drug Product Image Figure 3. Global Amino Acid Metabolism Disorder Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Amino Acid Metabolism Disorder Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Amino Acid Metabolism Disorder Drug Market Share by Region (2021-2032) Figure 7. North America Amino Acid Metabolism Disorder Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Amino Acid Metabolism Disorder Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Amino Acid Metabolism Disorder Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Folic Acid Image Figure 13. Global Folic Acid Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Sapropterin Dihydrochloride Image Figure 15. Global Sapropterin Dihydrochloride Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Vitamin D Image Figure 17. Global Vitamin D Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Vitamin B6 & B12 Image Figure 19. Global Vitamin B6 & B12 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Betaine Image Figure 21. Global Betaine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Thiamine Image Figure 23. Global Thiamine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Carglumic Acid Image Figure 25. Global Carglumic Acid Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Arginine Image Figure 27. Global Arginine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Others Image Figure 29. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. Global Amino Acid Metabolism Disorder Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 31. Global Amino Acid Metabolism Disorder Drug Market Share by Type 2025 VS 2032 Figure 32. North America Amino Acid Metabolism Disorder Drug Market Size Share by Type (2021-2032) Figure 33. Europe Amino Acid Metabolism Disorder Drug Market Size Share by Type (2021-2032) Figure 34. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size Share by Type (2021-2032) Figure 35. Latin America Amino Acid Metabolism Disorder Drug Market Size Share by Type (2021-2032) Figure 36. Middle East and Africa Amino Acid Metabolism Disorder Drug Market Size Share by Type (2021-2032) Figure 37. Argininosuccinic Acidemia Image Figure 38. Global Argininosuccinic Acidemia Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Citrullinemia Image Figure 40. Global Citrullinemia Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Homocystinuria Image Figure 42. Global Homocystinuria Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. Maple Syrup Urine Disease Image Figure 44. Global Maple Syrup Urine Disease Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. Phenylketonuria Image Figure 46. Global Phenylketonuria Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. Global Amino Acid Metabolism Disorder Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 48. Global Amino Acid Metabolism Disorder Drug Market Share by Application 2025 VS 2032 Figure 49. North America Amino Acid Metabolism Disorder Drug Market Size Share by Application (2021-2032) Figure 50. Europe Amino Acid Metabolism Disorder Drug Market Size Share by Application (2021-2032) Figure 51. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size Share by Application (2021-2032) Figure 52. Latin America Amino Acid Metabolism Disorder Drug Market Size Share by Application (2021-2032) Figure 53. Middle East and Africa Amino Acid Metabolism Disorder Drug Market Size Share by Application (2021-2032) Figure 54. Global Top 5 and 10 Amino Acid Metabolism Disorder Drug Players Market Share by Revenue in 2025 Figure 55. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 56. North America Amino Acid Metabolism Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. North America Amino Acid Metabolism Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. North America Amino Acid Metabolism Disorder Drug Market Share by Country (2021-2032) Figure 59. Europe Amino Acid Metabolism Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Amino Acid Metabolism Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Amino Acid Metabolism Disorder Drug Market Share by Country (2021-2032) Figure 62. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Share by Country (2021-2032) Figure 65. Latin America Amino Acid Metabolism Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Amino Acid Metabolism Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Amino Acid Metabolism Disorder Drug Market Share by Country (2021-2032) Figure 68. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 69. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 70. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Share by Country (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Folic Acid
  • Sapropterin Dihydrochloride
  • Vitamin D
  • Vitamin B6 & B12
  • Betaine
  • Thiamine
  • Carglumic Acid
  • Arginine
  • Others
Applications
  • Argininosuccinic Acidemia
  • Citrullinemia
  • Homocystinuria
  • Maple Syrup Urine Disease
  • Phenylketonuria
Companies covered
  • AMINO
  • BioMarin
  • DSM
  • Kyowa Hakko Kirin
  • Recordati
  • Shine Star (Hubei) Biological Engineering
  • Swedish Orphan Biovitrum
  • GlaxoSmithKline
  • Pfizer
  • Merck
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Amino Acid Metabolism Disorder Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Amino Acid Metabolism Disorder Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Amino Acid Metabolism Disorder Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Amino Acid Metabolism Disorder Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Amino Acid Metabolism Disorder Drug Market Size (2021-2032)
  8. 1.5.1 North America Amino Acid Metabolism Disorder Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Amino Acid Metabolism Disorder Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Amino Acid Metabolism Disorder Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size Growth Rate (2021-2032)
2 Amino Acid Metabolism Disorder Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Folic Acid
  3. 2.1.2 Sapropterin Dihydrochloride
  4. 2.1.3 Vitamin D
  5. 2.1.4 Vitamin B6 & B12
  6. 2.1.5 Betaine
  7. 2.1.6 Thiamine
  8. 2.1.7 Carglumic Acid
  9. 2.1.8 Arginine
  10. 2.1.9 Others
  11. 2.2 Global Amino Acid Metabolism Disorder Drug Market Size by Type
  12. 2.2.1 Global Amino Acid Metabolism Disorder Drug Market Size Overview by Type (2021-2032)
  13. 2.2.2 Global Amino Acid Metabolism Disorder Drug Historic Market Size Review by Type (2021-2026)
  14. 2.2.3 Global Amino Acid Metabolism Disorder Drug Market Size Forecasted by Type (2027-2032)
  15. 2.3 Global Amino Acid Metabolism Disorder Drug Market Size by Regions
  16. 2.3.1 North America Amino Acid Metabolism Disorder Drug Market Size Breakdown by Type (2021-2026)
  17. 2.3.2 Europe Amino Acid Metabolism Disorder Drug Market Size Breakdown by Type (2021-2026)
  18. 2.3.3 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size Breakdown by Type (2021-2026)
  19. 2.3.4 South America Amino Acid Metabolism Disorder Drug Market Size Breakdown by Type (2021-2026)
  20. 2.3.5 Middle East and Africa Amino Acid Metabolism Disorder Drug Market Size Breakdown by Type (2021-2026)
3 Amino Acid Metabolism Disorder Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Argininosuccinic Acidemia
  3. 3.1.2 Citrullinemia
  4. 3.1.3 Homocystinuria
  5. 3.1.4 Maple Syrup Urine Disease
  6. 3.1.5 Phenylketonuria
  7. 3.2 Global Amino Acid Metabolism Disorder Drug Market Size by Application
  8. 3.2.1 Global Amino Acid Metabolism Disorder Drug Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Amino Acid Metabolism Disorder Drug Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Amino Acid Metabolism Disorder Drug Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Amino Acid Metabolism Disorder Drug Market Size by Regions
  12. 3.3.1 North America Amino Acid Metabolism Disorder Drug Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Amino Acid Metabolism Disorder Drug Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Amino Acid Metabolism Disorder Drug Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Amino Acid Metabolism Disorder Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Amino Acid Metabolism Disorder Drug Industry Trends
  2. 4.2 Amino Acid Metabolism Disorder Drug Industry Drivers
  3. 4.3 Amino Acid Metabolism Disorder Drug Industry Opportunities and Challenges
  4. 4.4 Amino Acid Metabolism Disorder Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Amino Acid Metabolism Disorder Drug Revenue (2021-2026)
  2. 5.2 Global Amino Acid Metabolism Disorder Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Amino Acid Metabolism Disorder Drug Key Company Headquarters & Area Served
  4. 5.4 Global Amino Acid Metabolism Disorder Drug Company, Product Type & Application
  5. 5.5 Global Amino Acid Metabolism Disorder Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Amino Acid Metabolism Disorder Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Amino Acid Metabolism Disorder Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Amino Acid Metabolism Disorder Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 AMINO
  2. 6.1.1 AMINO Company Information
  3. 6.1.2 AMINO Business Overview
  4. 6.1.3 AMINO Amino Acid Metabolism Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 AMINO Amino Acid Metabolism Disorder Drug Product Portfolio
  6. 6.1.5 AMINO Recent Developments
  7. 6.2 BioMarin
  8. 6.2.1 BioMarin Company Information
  9. 6.2.2 BioMarin Business Overview
  10. 6.2.3 BioMarin Amino Acid Metabolism Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 BioMarin Amino Acid Metabolism Disorder Drug Product Portfolio
  12. 6.2.5 BioMarin Recent Developments
  13. 6.3 DSM
  14. 6.3.1 DSM Company Information
  15. 6.3.2 DSM Business Overview
  16. 6.3.3 DSM Amino Acid Metabolism Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 DSM Amino Acid Metabolism Disorder Drug Product Portfolio
  18. 6.3.5 DSM Recent Developments
  19. 6.4 Kyowa Hakko Kirin
  20. 6.4.1 Kyowa Hakko Kirin Company Information
  21. 6.4.2 Kyowa Hakko Kirin Business Overview
  22. 6.4.3 Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Product Portfolio
  24. 6.4.5 Kyowa Hakko Kirin Recent Developments
  25. 6.5 Recordati
  26. 6.5.1 Recordati Company Information
  27. 6.5.2 Recordati Business Overview
  28. 6.5.3 Recordati Amino Acid Metabolism Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Recordati Amino Acid Metabolism Disorder Drug Product Portfolio
  30. 6.5.5 Recordati Recent Developments
  31. 6.6 Shine Star (Hubei) Biological Engineering
  32. 6.6.1 Shine Star (Hubei) Biological Engineering Company Information
  33. 6.6.2 Shine Star (Hubei) Biological Engineering Business Overview
  34. 6.6.3 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Product Portfolio
  36. 6.6.5 Shine Star (Hubei) Biological Engineering Recent Developments
  37. 6.7 Swedish Orphan Biovitrum
  38. 6.7.1 Swedish Orphan Biovitrum Company Information
  39. 6.7.2 Swedish Orphan Biovitrum Business Overview
  40. 6.7.3 Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Product Portfolio
  42. 6.7.5 Swedish Orphan Biovitrum Recent Developments
  43. 6.8 GlaxoSmithKline
  44. 6.8.1 GlaxoSmithKline Company Information
  45. 6.8.2 GlaxoSmithKline Business Overview
  46. 6.8.3 GlaxoSmithKline Amino Acid Metabolism Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 GlaxoSmithKline Amino Acid Metabolism Disorder Drug Product Portfolio
  48. 6.8.5 GlaxoSmithKline Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Amino Acid Metabolism Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Pfizer Amino Acid Metabolism Disorder Drug Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 Merck
  56. 6.10.1 Merck Company Information
  57. 6.10.2 Merck Business Overview
  58. 6.10.3 Merck Amino Acid Metabolism Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Merck Amino Acid Metabolism Disorder Drug Product Portfolio
  60. 6.10.5 Merck Recent Developments
  61. 6.11 Sanofi
  62. 6.11.1 Sanofi Company Information
  63. 6.11.2 Sanofi Business Overview
  64. 6.11.3 Sanofi Amino Acid Metabolism Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Sanofi Amino Acid Metabolism Disorder Drug Product Portfolio
  66. 6.11.5 Sanofi Recent Developments
7 North America
  1. 7.1 North America Amino Acid Metabolism Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Amino Acid Metabolism Disorder Drug Market Size by Country (2021-2026)
  3. 7.3 North America Amino Acid Metabolism Disorder Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Amino Acid Metabolism Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Amino Acid Metabolism Disorder Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Amino Acid Metabolism Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Amino Acid Metabolism Disorder Drug Market Size by Country (2021-2026)
  3. 10.3 South America Amino Acid Metabolism Disorder Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst